ABOUT US
The team
Maurice Lubetzki
CEO
Entrepreneur, Engineer
Clément Dubois
CTO
Entrepreneur, Engineer
Murielle Rochelet
CSO, inventor
PhD in Electrochemistry
Elodie Barbier
Research scientist, Inventor
PhD in microbiology
Manon Giraud
Head of R&D
PhD in Microtechnologies, Engineer
_edited.jpg)
Raphaëlle Paounov
R&D scientist
Biomedical and microfluidic engineer
Lina Ait-Ameur
R&D scientist
Microbiologist
Daphné Joly
Head of manufacturing
Engineer
A complementary team driven by a same goal : build the best screening tool for tuberculosis and diagnose the 4 million people undetected each year !
Join epilab
Théo Fouchet
Head of samples, PhD student
Microbiologist, Engineer
Melissa Nait Chabane
R&D scientist
Microbiologist
Christina Gbelay
Head of regulatory affairs
Medical engineer
Scientific Board
Dr. Lucas Esuh Esong
Member of the PNLT (National program to fight tuberculosis) in Cameroon; consultant for WHO on tuberculosis in Africa and founder of the Always Care Foundation, which promotes access to care and education in underprivileged communities.
Dr. Esuh Esong is well acquainted with the problems associated with field diagnosis and is currently helping EpiLAB organise clinical studies in Central and Sub-Saharan Africa.
Julien Reboud, PhD
Dr Julien Reboud is a teacher in Biomedical Engineering at the University of Glasgow and has an extensive track record in developing and integrating low cost microfluidic systems for measurement of multiple disease states, including in low-resource settings.
After his PhD on new microfluidic technologies , Julien worked on new biosensors for medical diagnostics. He is currently a co-founder of Acu-Flow Ltd, which won the Scottish Edge in 2019.
Dr. Laurent Raskine
Expert in tuberculosis and international operations for Mérieux Foundation.
His extensive experience in the field and his vast knowledge about the disease disease make him uniquely positioned to guide EpiLAB through scientific research and product development. Laurent Raskine has already set up laboratories and deployed tests in the countries where EpiLAB plans to establish operations, particularly in Africa.
Origin of Epilab
Learn more about our project's creation !
When ?
During the first lockdown in March 2020
Why ?
Clément Dubois is interested in the valorisation of French technologies
How ?
He connected with several SATT (technology acceleration and transfer company).From SATT Sayens, the EDMYC process "new portable and easy to use kit for tuberculosis diagnosis" hooked his attention.
Who ?
With the two technology inventors, Murielle Rochelet, Elodie Barbier, and Maurice Lubetzki, former entrepreneur, they decided to take over the EDMYC patent and created EpiLAB.
Achievements
Meeting Frédérique Vidal, at Viva Technology event
June 2021
Viva technology, Europe's biggest startup and tech event, was organised in june 2021 in Paris. Epilab had the opportunity to present its solution on a stand and meet several potential partners.
Special thanks to Frederic Vidal, Minister of Higher Education, Research and Innovation, to whom we presented the EpiLAB solution.
Interview with Epilab at France biotech
June 2021
France Biotech is the French trade association of biotechnology companies. Its primary mission is to support the development of this industry in France.
Epilab was the subject of the 5th episode of its "Pépites Healthtech" series where France Biotech present promising start-ups.
Epilab in Les Echos
February 2021
Article in Les Echos, looking back at the beginnings of the start-up and the collaboration with SATT Sayens. Sayens has overseen the maturation of the innovation based on the electrochemical detection of tuberculosis, and now becomes a minor shareholder of the company to help deploy this rapid diagnostic kit on a global scale.
Epilab joins Cerba Healthcare's virtual incubator
November 2021
By joining the Virtual Incubator of Cerba HealthCare Group, already widely established in Africa, EpiLAB will be able to accelerate the development of its test and its widespread use. The collaboration with Cerba HealthCare will allow Epilab to propose a product as close as possible to the needs of the field, in order to facilitate its adoption by healthcare professionals and optimize its integration into new patient pathways.
Epilab at ChangeNOW
May 2022
Epilab had the opportunity present the solution for TB detection at ChangeNOW, the world’s largest event for the planet
Every year, it brings together the most innovative solutions and impactful changemakers tackling our planet’s biggest challenges, to take action, together. ChangeNOW builds bridges between the entrepreneurs, business leaders and policy-makers to accelerate change.
Epilab joins La French Tech Paris Saclay community
February 2021
French Tech Paris-Saclay represents the interests of a community of start-ups, scaleups and project leaders in the Paris-Saclay, Yvelines and Essonne area.
Epilab is selected by SNITEM for the 6th "day of the innovative Startup of the medical device"!
January 2021
SNITEM (Syndicat National de l'Industrie des Technologies Médicales) is the leading professional organisation representing most of the Medical Devices and Health ICT industryies. It federates more than 500 companies.
Epilab is labeled DeepTech Pioneer by Hello Tomorrow
November 2020
Hello tomorrow is a mission-driven global organisation that aims to accelerate the transfer of deep technologies to solve some of our most pressing industrial, environmental and societal challenges. For its global summit, they selects start-ups that are game-changers developing cutting-edge technology to bring positive change to our planet, society and industries : DeepTech Pioneers.
Our partners
Participation in two challenges
October 2020
EpilAB wins the Prix de l'ingénierie du futur by SYNTEC (https://www.youtube.com/watch?v=k3a0yH9jWDg&ab_channel=Concepteursd%27Avenirs) and reaches the final of the challenge of Centrale Schools
